In another sample of 527 women diagnosed with stage I–IIIA breast cancer, adiponectin levels above 15.5 μg/mL were associated with improved breast cancer survival (HR = 0.39; 95% CI, 0.15–0.95) [43]. This evidence concerns the gene ADIPOQ and breast carcinoma.